Serum selenium levels, glutathione peroxidase activities and serum redox potential levels in patients with untreated non-small cell lung cancer and adenocarcinoma of the rectum

Trace Elements and Electrocytes

Volumn 17, Issue 3, 2000, Pages 119-123

  Mucke R ^a   Micke, O ^b   Schonekaes K G ^c  

^a Klin Poliklin Strahlentherapie U   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c Paracelsus Klinik Osnabruck   (Germany)

Author keywords

Adenocarcinoma of the rectum; Glutathione peroxidase; Non small cell lung cancer; Redox potential; Selenium

Indexed keywords

GLUTATHIONE PEROXIDASE; OXYGEN RADICAL; SELENIUM;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER THERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME ACTIVITY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MALE; OXIDATION REDUCTION POTENTIAL; PATHOGENESIS; PATHOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; QUALITY OF LIFE; RECTUM CARCINOMA;

EID: 17444452425     PISSN: 09462104     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Coates RJ, Weiss NS, Dailing JR, Morris JS, Lahbe RF 1988 Serum levels of selenium and retinal and subsequent risk of cancer. Am J Epidemiol 135: 115-121
2. Clark LC 1985 The epidemiology of selenium and cancer. Fed Proc 44: 2584
3. Clark LC, Combs GF, Turnhull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, Krongrad A, Lesher JL, Park HK, Sanders BB, Smith CI, Taylor JR 1996 Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. JAMA 276; 1957-1963
4. Diamond AM, Dale P, Murray JL, Grdina DJ 1996 The inhibition of radiation-induced mutagenesis by the combined effects of selenium and the aminothiol WR-1065. Mutat Res 356: 147-154
5. Hamann D, Heinrich H 1989 Änderung des Redox-potentials in Serumproben nach In-vitro-Bestrahlung - ein Indikator fur malignes Geschwulstwachstum. Radiobiol Radiother 30: 525-532
6. Hissan PJ, Hilf R 1976 A fluorometric method for determination of oxided and reduced glutathione in tissues. Anal Biochem 74: 214-126
7. Iyengar V, Woittiez J 1988 Trace elements in human clinical specimens: evaluation of literature data to identify reference values. Clin Chem 34: 474-481
8. Knekt P, Aromaa A, Mantela J 1990 Serum selenium and subsequent risk of cancer among Finnish men and woman. J Natl Cancer Inst 82: 864-868
9. Knekt P, Aromaa A, Mantela J 1988 Serum vitamin E, serum selenium and the risk of gastrointestinal cancer. Int J Cancer 42: 846-850
10. Landone L, Jean Y, Roberts KD, Chapdelaine A, Bleau G 1982 Fluorometry of selenium in serum or urine. Clin Chem 28: 172-174
11. Menkes MS 1986 Serum β-carotene, vitamin A and E, Se and the risk of lung cancer. N Engl J Med 3/5: 1250-1254
12. Mücke R, Jaekel R, Sleiner M, Anders O, Ernst B 1994 Erythrocyte and whole blood superoxide dismutase activity in chronic myeloproliferative disorders. Klin Lab 40: 323-326
13. Newberne PM, Charley G, Adams K, Cantor M, Roth D, Supharkan V 1986 Gastric and oesophageal carcinogenesis. Food Chem Toxicol 24: 1111-1119
14. Oberley LW, Oberley TD 1988 The role of antioxidant enzymes in cell immortalization and transformation. Mol Cell Biochem 84: 147-153
15. Patchen ML, MacVittie TJ, Weiss JF 1990 Combined modality radioprotection: the use of glucan and selenium with WR-2721. Int J Radiat Oncol Biol Phys 18: 1069-1075
16. Pawlowicz, Zachara BA, Trafikowska U, Maciag A, Marchaluk E, Nowicki A 1991 Blood selenium concentrations and glutathione peroxidase activities in patients with breast cancer and with advanced gastrointestinal cancer. J Trace Elem Electrolytes Health Dis 5: 272-277
17. Pawlowicz Z, Zachara BA, Trafikowska U, Nowicki A 1993 Low levels of selenium and activity of glutathione peroxidase in blood of patients with gastrointestinal neoplasma. Pol Tyg Lck 48: 554-556
18. Ringstad J, Jacobsen BK, Tretli S, Thomassen Y 1988 Serum selenium concentration associated with risk of cancer. J Clin Pathol 41: 454-457
19. Saito T, Kurasaki M, Kaji H, Saito K 1984 Deficiency of erythrocyte superoxide dismutase and catalase activities in patients with malignant lymphoma and acute myeloid leukaemia. Cancer Lett 24: 141-146
20. Salonen JT, Alfthan G, Huttunen JK, Puska P 1984 Association between serum selenium and the risk of cancer. Am J Epidemiol 120: 342-349
21. Salonen JT, Salonen R, Lappeteläinen R, Mäenpää PH, Alfthan G, Puska P 1985 Risk of cancer in relation to serum concentrations of selenium and vitamins A and E. BMJ 290: 417-420
22. Shu-You Y, Ya-Jun Z, Wen-Guang Li, Qui-Sheng H, Zhi-Huang Ch, Qi-Nan Zh, Chong H 1991 A preliminary report on the intervention trials of primary liver cancer in high-risk populations with nutritional supplementation of selenium in China. Biol Trace Elem Res 29: 289-294
23. Torun M, Aldemir H, Yardim S 1995 Serum selenium levels in various cancer types. Trace Elem Electrolytes 12: 186-190
24. Turan B, Delilbasi E 1992 The serum selenium and immunoglobulin levels in healthy and cancer cases. J Biochem 17: 29-36
25. Vermeulen N, Baldew GS, Los G, McVie JG, De Goeij JM 1993 Reduction of cispiatinum nephrotoxicity by sodium selenite. Drug Metab Dispos 21: 30-36
26. Willet W, Polk B, Morris S 1983 Prediagnostic serum selenium and risk of cancer. Lancet 2: 130-134